Accumulating evidence indicates that obesity is closely associated with an increased risk of
metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases
worldwide, as it affects up to 30% of adults in Western countries. Moreover, NAFLD is also …

Insulin resistance (IR) is the pathophysiological hallmark of nonalcoholic fatty liver disease
(NAFLD), one of the most common causes of chronic liver disease in Western countries. We …

Adiponectin is an important adipocytokine secreted chiefly by fat containing adipocytes, and
plays a crucial role in glucose and lipid metabolism, inflammation and oxidative stress …

Non-alcoholic fatty liver disease (NAFLD) comprising hepatic steatosis, non-alcoholic
steatohepatitis (NASH), and progressive liver fibrosis is considered the most common liver …

Patients with fatty liver (FL) disease have a high risk of developing diabetes and
cardiovascular diseases. The aim was to evaluate the association between FL, insulin …

Nonalcoholic fatty liver disease (NAFLD), the major reason for abnormal liver function in the
Western world, is associated with obesity and diabetes and is characterized by insulin …

Plasma levels of adiponectin are decreased in patients with nonalcoholic fatty liver disease
(NAFLD), but the relationship among plasma adiponectin, insulin sensitivity, and histological …

Nonalcoholic fatty liver disease prevalence in Western countries is high and there is a trend
towards a further increase, with millions of people at risk of advanced liver disease. The …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver-related
morbidity and mortality. It can develop secondary to numerous causes but a great majority of …